🇺🇸 FDA
Pipeline program

Fluocinolone Acetonide Intravitreal Implant 0.18 mg

EYP-YUT-002

Approved small_molecule active

Quick answer

Fluocinolone Acetonide Intravitreal Implant 0.18 mg for Uveitis, Posterior is a Approved program (small_molecule) at ANI PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
ANI PHARMACEUTICALS INC
Indication
Uveitis, Posterior
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials